KTTA
Price
$0.76
Change
-$0.01 (-1.30%)
Updated
Sep 9, 04:57 PM (EDT)
Capitalization
5.81M
LXEO
Price
$5.19
Change
-$0.06 (-1.14%)
Updated
Sep 9, 04:59 PM (EDT)
Capitalization
283.51M
Interact to see
Advertisement

KTTA vs LXEO

Header iconKTTA vs LXEO Comparison
Open Charts KTTA vs LXEOBanner chart's image
Pasithea Therapeutics
Price$0.76
Change-$0.01 (-1.30%)
Volume$1.29K
Capitalization5.81M
Lexeo Therapeutics
Price$5.19
Change-$0.06 (-1.14%)
Volume$4.51K
Capitalization283.51M
KTTA vs LXEO Comparison Chart in %
Loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KTTA vs. LXEO commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KTTA is a StrongBuy and LXEO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 10, 2025
Stock price -- (KTTA: $0.77 vs. LXEO: $5.25)
Brand notoriety: KTTA and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KTTA: 92% vs. LXEO: 87%
Market capitalization -- KTTA: $5.81M vs. LXEO: $283.51M
KTTA [@Biotechnology] is valued at $5.81M. LXEO’s [@Biotechnology] market capitalization is $283.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KTTA’s FA Score shows that 1 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • KTTA’s FA Score: 1 green, 4 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, KTTA is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KTTA’s TA Score shows that 5 TA indicator(s) are bullish while LXEO’s TA Score has 4 bullish TA indicator(s).

  • KTTA’s TA Score: 5 bullish, 4 bearish.
  • LXEO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than LXEO.

Price Growth

KTTA (@Biotechnology) experienced а -4.69% price change this week, while LXEO (@Biotechnology) price change was +9.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.20%. For the same industry, the average monthly price growth was +11.70%, and the average quarterly price growth was +36.33%.

Industries' Descriptions

@Biotechnology (+2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXEO($284M) has a higher market cap than KTTA($5.81M). LXEO YTD gains are higher at: -20.213 vs. KTTA (-75.546). KTTA has higher annual earnings (EBITDA): -13.11M vs. LXEO (-111.97M). LXEO has more cash in the bank: 133M vs. KTTA (7.22M). KTTA has less debt than LXEO: KTTA (0) vs LXEO (8.91M). KTTA (0) and LXEO (0) have equivalent revenues.
KTTALXEOKTTA / LXEO
Capitalization5.81M284M2%
EBITDA-13.11M-111.97M12%
Gain YTD-75.546-20.213374%
P/E RatioN/AN/A-
Revenue00-
Total Cash7.22M133M5%
Total Debt08.91M-
TECHNICAL ANALYSIS
Technical Analysis
KTTALXEO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
70%
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBGLY15.760.34
+2.20%
Reckitt Benckiser Group Plc.
NXNIF0.16N/A
+0.23%
NORTHX NICKEL CORP.
OCLDY14.22N/A
N/A
Orica Ltd.
UHOIF14.21N/A
N/A
Ushio Inc.
HAIVF3.35N/A
N/A
HAIVISION SYS INC .

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and LXEO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and LXEO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-2.52%
LXEO - KTTA
28%
Poorly correlated
+4.58%
INCY - KTTA
28%
Poorly correlated
-0.09%
GNFT - KTTA
26%
Poorly correlated
+0.51%
SCNI - KTTA
23%
Poorly correlated
+1.33%
TRAW - KTTA
22%
Poorly correlated
+3.91%
More

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
+4.58%
BEAM - LXEO
45%
Loosely correlated
-4.50%
COGT - LXEO
44%
Loosely correlated
-2.84%
RGNX - LXEO
43%
Loosely correlated
-2.37%
VTYX - LXEO
42%
Loosely correlated
-5.56%
RNA - LXEO
42%
Loosely correlated
-4.59%
More